Clinical relevance
Connect scientific evidence and product questions to the realities of allergy practice and patient care.
FAAAAI · FACAAIScientific advisory & consulting
Dr. Wallace advises pharmaceutical and biotechnology organizations on medical, scientific, educational, and clinician-facing questions in allergy and immunology.
Current advisory work
ARS · Aquestive · Bryn · ALK-Abelló, Inc. · Kenvue
Her perspective draws on community practice, academic teaching, evidence synthesis, guideline development, professional-society leadership, and decades of communicating with clinicians.
Connect scientific evidence and product questions to the realities of allergy practice and patient care.
Shape credible clinician-facing education, faculty programs, learning tools, and scientific communication.
Bring a long view of guidelines, professional organizations, emerging therapies, and changing practice needs.
Previous advisory & consulting
ARS, Bryn, Genentech, Grifols, Kaléo, and AbbVie
Sanofi, Kaléo, Mylan, ALK, Bryn, and Optinose
MEDA, Sanofi, Mylan, LifeReach, Kaléo, DVB, Allergan, and Medical Marketing Solutions
Mylan, MEDA, Sanofi, NeoHealth, and related product-specific advisory work
Historical activity—presented separately
Promotional speaker-bureau work is historical and is intentionally distinguished from current and past advisory/consulting activity.
Sanofi, Kaléo, Optinose, and ALK
Mylan and Kaléo
MEDA
Mylan and MEDA
Mylan/MEDA, Sunovion, and TEVA
Mylan, Sunovion, and TEVA speaker training
Advisory inquiries